|
1
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Wu Y, Wang YQ, Weng WW, Zhang QY, Yang XQ,
Gan HL, Yang YS, Zhang PP, Sun MH, Xu MD and Wang CF: A
serum-circulating long noncoding RNA signature can discriminate
between patients with clear cell renal cell carcinoma and healthy
controls. Oncogenesis. 5(e192)2016.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Kitching R, Li H, Wong MJ, Kanaganayakam
S, Kahn H and Seth A: Characterization of a novel human breast
cancer associated gene (BCA3) encoding an alternatively spliced
proline-rich protein. Biochim Biophys Acta. 1625:116–121.
2003.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Lin C, Song L, Liu A, Gong H, Lin X, Wu J,
Li M and Li J: Overexpression of AKIP1 promotes angiogenesis and
lymphangiogenesis in human esophageal squamous cell carcinoma.
Oncogene. 34:384–393. 2015.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Mo D, Li X, Li C, Liang J, Zeng T, Su N,
Jiang Q and Huang J: Overexpression of AKIP1 predicts poor
prognosis of patients with breast carcinoma and promotes cancer
metastasis through Akt/GSK-3β/Snail pathway. Am J Transl Res.
8:4951–4959. 2016.PubMed/NCBI
|
|
7
|
Jiang W, Yang W, Yuan L and Liu F:
Upregulation of AKIP1 contributes to metastasis and progression and
predicts poor prognosis of patients with colorectal cancer. Onco
Targets Ther. 11:6795–6801. 2018.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Sun Y, Shi G, Ma C, Jiao J, Liu Y, Gao Q,
Zhang X and Feng Q: Upregulation of a kinase interacting protein 1
in tongue squamous cell carcinoma correlates with lymph node
metastasis and poor overall survival. Medicine (Baltimore).
100(e25278)2021.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Guo X, Zhao L, Cheng D, Mu Q, Kuang H and
Feng K: AKIP1 promoted epithelial-mesenchymal transition of
non-small-cell lung cancer via transactivating ZEB1. Am J Cancer
Res. 7:2234–2244. 2017.PubMed/NCBI
|
|
10
|
Peng H, Zhang R and Zhang H: A-kinase
interacting protein 1 high expression correlates with advanced
tumor stage and poor overall survival in surgical patients with
clear cell renal cell carcinoma. Medicine (Baltimore).
99(e20742)2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Yao C, Yu KP, Philbrick W, Sun BH, Simpson
C, Zhang C and Insogna K: Breast cancer-associated gene 3 interacts
with Rac1 and augments NF-κB signaling in vitro, but has no effect
on RANKL-induced bone resorption in vivo. Int J Mol Med.
40:1067–1077. 2017.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Chen L, Zhang D, Ding T, Liu F, Xu X, Tian
Y, Xiao J and Shen H: LncRNA NR2F2-AS1 Upregulates Rac1 to increase
cancer stemness in clear cell renal cell carcinoma. Cancer Biother
Radiopharm. 35:301–306. 2020.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Hsieh YY, Liu TP and Yang PM: In silico
repurposing the Rac1 inhibitor NSC23766 for treating PTTG1-high
expressing clear cell renal carcinoma. Pathol Res Pract.
215(152373)2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Zhang T, Wang Z, Liu Y, Huo Y, Liu H, Xu
C, Mao R, Zhu Y, Liu L, Wei D, et al: Plastin 1 drives metastasis
of colorectal cancer through the IQGAP1/Rac1/ERK pathway. Cancer
Sci. 111:2861–2871. 2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Ma D, Li M, Su J and Zhang S: BCA3
contributes to the malignant progression of hepatocellular
carcinoma through AKT activation and NF-κB translocation. Exp Cell
Res. 362:142–151. 2018.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Zhang W, Wu Q, Wang C, Yang L, Liu P and
Ma C: AKIP1 promotes angiogenesis and tumor growth by upregulating
CXC-chemokines in cervical cancer cells. Mol Cell Biochem.
448:311–320. 2018.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Cui Y, Wu X, Lin C, Zhang X, Ye L, Ren L,
Chen M, Yang M, Li Y, Li M, et al: AKIP1 promotes early recurrence
of hepatocellular carcinoma through activating the
Wnt/β-catenin/CBP signaling pathway. Oncogene. 38:5516–5529.
2019.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Bosco EE, Mulloy JC and Zheng Y: Rac1
GTPase: A ‘Rac’ of all trades. Cell Mol Life Sci. 66:370–374.
2009.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Zhang S, Shi W, Hu W, Ma D, Yan D, Yu K,
Zhang G, Cao Y, Wu J, Jiang C and Wang Z: DEP Domain-Containing
Protein 1B (DEPDC1B) promotes migration and invasion in pancreatic
cancer through the Rac1/PAK1-LIMK1-Cofilin1 signaling pathway. Onco
Targets Ther. 13:1481–1496. 2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Kato T, Kawai K, Egami Y, Kakehi Y and
Araki N: Rac1-dependent lamellipodial motility in prostate cancer
PC-3 cells revealed by optogenetic control of Rac1 activity. PLoS
One. 9(e97749)2014.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Tian Y, Xu L, He Y, Xu X, Li K, Ma Y, Gao
Y, Wei D and Wei L: Knockdown of RAC1 and VASP gene expression
inhibits breast cancer cell migration. Oncol Lett. 16:2151–2160.
2018.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Xie N, Meng Q, Zhang Y, Luo Z, Xue F, Liu
S, Li Y and Huang Y: MicroRNA-142-3p suppresses cell proliferation,
invasion and epithelial-to-mesenchymal transition via RAC1-ERK1/2
signaling in colorectal cancer. Mol Med Rep. 24(568)2021.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Wacker I and Behrens J: Activin B
antagonizes RhoA signaling to stimulate mesenchymal morphology and
invasiveness of clear cell renal cell carcinomas. PLoS One.
9(e111276)2014.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Wang LL, Luo J, He ZH, Liu YQ, Li HG, Xie
D and Cai MY: STEAP3 promotes cancer cell proliferation by
facilitating nuclear trafficking of EGFR to enhance
RAC1-ERK-STAT3 signaling in hepatocellular
carcinoma. Cell Death. Dis. 12(1052)2021.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Jiang QH, Wang AX and Chen Y: Radixin
enhances colon cancer cell invasion by increasing MMP-7 production
via Rac1-ERK pathway. ScientificWorldJournal.
2014(340271)2014.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Zhao SJ, Shen YF, Li Q, He YJ, Zhang YK,
Hu LP, Jiang YQ, Xu NW, Wang YJ, Li J, et al: SLIT2/ROBO1 axis
contributes to the Warburg effect in osteosarcoma through
activation of SRC/ERK/c-MYC/PFKFB2 pathway. Cell Death Dis.
9(390)2018.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Sharma BK, Kolhe R, Black SM, Keller JR,
Mivechi NF and Satyanarayana A: Inhibitor of differentiation 1
transcription factor promotes metabolic reprogramming in
hepatocellular carcinoma cells. FASEB J. 30:262–275.
2016.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Dai L, Wang W, Liu Y, Song K and Di W:
Inhibition of sphingosine kinase 2 down-regulates ERK/c-Myc pathway
and reduces cell proliferation in human epithelial ovarian cancer.
Ann Transl Med. 9(645)2021.PubMed/NCBI View Article : Google Scholar
|
